- This event has passed.
Lessons in Herding Cats – Business Development Basics for Life Science Companies
April 28, 2016 @ 11:30 am - 1:00 pm
The business development professional’s purpose is to optimize optionality and long term value at each stage of a company’s life. As a company grows and gains traction, it’s easy to get enticed and overwhelmed by the numerous opportunities that arise. How do you determine the direction that will add the most value to your company? How do you avoid the constant pursuit of “shiny objects?” How do you know when it’s the right time for a strategic partnership?
In this workshop, you’ll learn fundamental business development skills to help you successfully evaluate and manage strategic alliances and other potential growth opportunities.
Topics will include:
- Strategic alliance process management
- Concepts in valuation
- Importance of IP and IP diligence
- Communication and negotiation skills
- Basic components of a contract
This workshop is geared towards business development professionals and management teams of life science startups.
Parth Chakrabarti | Senior Director, Transactions, Johnson & Johnson Innovation read bio»
11:30 AM | Registration Opens, Networking & Lunch
12:00 PM | Presentations
12:45 PM | Q&A
1:00 PM | Program Close
CA$ 40 | General Public
CA$ 30 | Student/Academic
CA$ 55 | At the door
BMO Education & Conference Centre
60 Leonard Avenue – Krembil Discovery Tower
Toronto, ON M5T 2S8
Parth Chakrabarti, MBA | Senior Director, Transactions, Johnson & Johnson Innovation
Parth is Senior Director of Transactions at Johnson & Johnson Innovation, Boston. During his 15 years in the healthcare industry, Parth has been passionate about innovation in science and in business/transaction models. Before joining Johnson & Johnson Innovation, Parth was a Director at Baxter BioScience where he helped build two new business units focused on oncology and specialty immunology entirely through licensing and external partnerships. Prior to that, he led the establishment of ‘Innovation Cell’ at Becton Dickinson & Co. that successfully established new growth strategy for its Medical Surgical Systems business unit. He and his team then successfully executed the strategy through a combination of acquisitions and partnership agreements to build a new business franchise. Before Becton Dickinson, Parth was an Investment manager at VenturEast Capital, one of the few pure-play healthcare focused venture funds based in India that specialize in cross-border company creation through early stage equity investment. Before transitioning to the business side of healthcare, Parth spent 10 years as a scientist, most of it at Amgen Inc. working on variety of targets likes G-protein coupled receptor agonists and P-38 Kinase inhibitors as well as in a range of therapeutic areas like neuropathic pain, breast cancer & Alzheimer’s disease. His research contributed to advancement of three candidates to clinical development. Parth is an inventor in 23 granted patents and has co-authored multiple peer-reviewed papers that have garnered more than 450 citations. He has a Master’s degree in Healthcare Management from Harvard University, MBA from ISB, M. Pharm. (Medicinal Chemistry) from Indian Institute of Technology and a B. Pharm. from Nagpur University.